A University of Pittsburgh research group, Program Evaluation and Research Unit (PERU), has developed a novel educational tool for clinicians focusing on cannabis/marijuana. This educational tool is designed to inform healthcare professionals on the impacts of cannabis/marijuana consumption and to encourage clinicians to engage with patients who use the substance. Through increased engagement with patients, primary care clinicians can monitor and recognize problematic use, misuse, and dependence on cannabis. The resulting benefits can include decreasing the stigma associated with substance use disorder and improving patient outcomes.
Description
Cannabis/marijuana is the most used federally illegal drug in the United States, with about one-fifth of Americans having used it at least once. In recent years more states have legalized cannabis for recreational use, which has led to increased cannabis consumption in the general population. However, the fact that cannabis is legal does not mean it is safe. Frequent cannabis use is linked to cannabis use disorder (CUD) and mental health conditions (including psychosis and schizophrenia). Children and young people using cannabis are particularly susceptible to these risks. This novel educational tool will enable primary care clinicians to better engage with patients about cannabis use, identify those most at risk of its adverse effects, (including CUD), and provide the understanding and tailored support patients may require.
Applications
• Primary care physician training
• Community healthcare professional training
• Pediatric and adolescent healthcare provider training
Advantages
Recreational and medicinal cannabis use is rising. Among users, 1 in 10 will develop CUD (i.e., addiction), rising to 1 in 6 for those who begin using cannabis before the age of 18. Aside from dependency, cannabis use can impair cognition, impact learning and driving skills, and is associated with poor respiratory health and the development of some mental health disorders. Additionally, use during pregnancy increases the likelihood of adverse birth outcomes. Therefore, there is a need for primary care physicians to understand their patients’ cannabis use and offer support where required.
This novel educational tool is designed to provide helpful insight to healthcare professionals (HCPs) about the risks associated with cannabis consumption, including synthetic cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD). Information is provided on risk factors associated with excessive cannabis use, the signs of CUD, and why patients choose to use cannabis. Through this understanding, clinicians are better able to engage with patients.
Invention Readiness
A tool has been developed to educate clinicians in the key areas of cannabis use. HCPs learn how to use the POLAR*S approach to engage in open-ended questions and other communication strategies that provide insight about their patients’ cannabis habits. Clinicians learn to be pragmatic and recognize that abstinence is not a realistic approach for everyone. Finally, clinicians also learn how to initiate and support harm-reduction strategies if needed.
IP Status
Copyright
